Dr. Hidetaka Kitazono, MD

Dr. Kitazono practices at Guam Memorial Hospital in Tamuning, Guam, part of Government of Guam.

Dr. Kitazono's NPI, 1033316104, was assigned on June 29, 2007. Dr. Kitazono holds Ohio license 35.127810.

Dr. Kitazono's primary practice is Guam Memorial Hospital, at 85O Gov Carlos G Camacho Road, Tamuning, GU 96913 in Guam County. The practice phone is (671) 647-2552. The NPI Registry lists Dr. Kitazono's practice address as 100 Medical Center Dr, Springfield, OH 45504.

Dr. Kitazono's primary practice is Guam Memorial Hospital in Tamuning, Guam, part of Government of Guam. The medical group on file is Guam Memorial Hospital Authority (Guam Memorial Hospital).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kitazono practices. Vendor and product names are available with a free account.

Hospitalist is Dr. Kitazono's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Kitazono is licensed in Ohio.

CMS data shows 789 Medicare services from Dr. Kitazono across 5 procedure codes in 2024, for 138 Medicare patients. Medicare paid $56,400 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 138 Medicare patients who saw Dr. Kitazono in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have diabetes, and 75% have high blood pressure. 28% are also on Medicaid. Their average risk score is 3.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kitazono's median patient age at 62, with 45% women.

In 2024, Dr. Kitazono wrote 11 Medicare Part D claims. 100% of them were for generic drugs. They cover 22 drugs, with $25,609 in total drug cost. In 2018, CMS named 446 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Kitazono for performance year 2024, reported as part of a group. Dr. Kitazono accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Kitazono, published from 2011 to 2019. 2015 was the busiest year, with 3. The most frequent topics are Anti-Bacterial Agents, Japan and Clostridioides difficile. Dr. Kitazono has published most often in Anaerobe. Dr. Kitazono's most frequent co-authors are Gautam Anil Deshpande, MD, Erik R. Dubberke, MD and Nina M. Clark.

CMS Open Payments shows 14 general payments to Dr. Kitazono from 4 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $169.